Showing results (81-90 of 239) with videos related to

Sort By:
Pageof 24
Breast (Edinburgh, Scotland)|April 26, 2020
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemicGiuseppe Curigliano, Maria Joao Cardoso, Philip Poortmans, et al.
Breast (Edinburgh, Scotland)|November 26, 2025
Improving communication between healthcare professionals and patients living with advanced breast cancer: a global expert review and call-to-action for 2025-2035 (Goal 5)Lesley Fallowfield, Fran Boyle, Renate Haidinger, et al.
The Oncologist|April 1, 2014
Eribulin monotherapy in patients aged 70 years and older with metastatic breast cancerHyman Muss, Javier Cortes, Linda T Vahdat, et al.
International Journal of Clinical Oncology|August 31, 2002
Predictive molecular markers in the adjuvant therapy of breast cancer: state of the art in the year 2002Angelo Di Leo, Fatima Cardoso, Virginie Durbecq, et al.
Breast Cancer Research and Treatment|August 21, 2002
Evaluation of HER-2/NEU protein expression in breast cancer by immunohistochemistry: an interlaboratory study assessing the reproducibility of HER-2/NEU testingDavid Gancberg, Tero Järvinen, Angelo di Leo, et al.
Breast (Edinburgh, Scotland)|September 9, 2022
Current and future burden of breast cancer: Global statistics for 2020 and 2040Melina Arnold, Eileen Morgan, Harriet Rumgay, et al.
Clinical Breast Cancer|December 9, 2004
Potential predictive value of Bcl-2 for response to tamoxifen in the adjuvant setting of node-positive breast cancerFatima Cardoso, Marianne Paesmans, Denis Larsimont, et al.
Anticancer Research|August 15, 2002
HER-2/neu evaluation by immunohistochemistry and fluorescence in situ hybridization in breast cancer: implications for daily laboratory practiceDenis Larsimont, Angelo Di Leo, Ghizlane Rouas, et al.
The Lancet. Oncology|February 14, 2018
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer GroupHans Wildiers, Konstantinos Tryfonidis, Lissandra Dal Lago, et al.
Breast (Edinburgh, Scotland)|February 17, 2012
Clinical and pharmacokinetic study of sunitinib and docetaxel in women with advanced breast cancerJonas Bergh, Gabriella Mariani, Fatima Cardoso, et al.
Pageof 24